Linda Beza Joins the National Health Council as Vice President, Finance & Administration

Washington, DC – November 10, 2021 – The National Health Council (NHC) has named Linda Beza, as Vice President, Finance & Administration. In this newly created, leadership position, Beza will lead NHC’s finances, human resources, and oversee the day-to-day administration of the NHC.

“We are thrilled to have Linda join the NHC team,” said Randall L. Rutta, NHC’s Chief Executive Officer. “Her roll-up your sleeves and get the job done attitude is a good fit with the rest of the team. Linda’s extensive experience in finance, human resources, and operations combined with her passion for our mission will serve our members well.”

Most recently, Beza was the Senior Director of Finance and Administration at the Pool and Hot Tub Alliance where she lead the inhouse transition of finance, operations, and human resources from outsourced services and was instrumental in spearheading the merger of PHTA. Prior to that, she was the Controller at the Association of Air Medical Services and MedEvac Foundation Int’l., the Accountant and Benefits Manager at the National Association of College and University Attorneys, Senior Auditor at Gelman Rosenberg & Freedman, and a Finance Analyst at Ferris, Baker Watts Inc.

Beza earned her Master of Business Administration from the University of Maryland, University College in College Park, MD and her Bachelor of Science in Accounting from Lincoln University in Jefferson City, MO.

# # #

About the NHC

Created by and for patient organizations 100 years ago, the National Health Council (NHC) brings diverse organizations together to forge consensus and drive patient-centered health policy. We promote increased access to affordable, high-value, sustainable health care. Made up of more than 140 national health-related organizations and businesses, the NHC’s core membership includes the nation’s leading patient organizations. Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses representing biopharmaceutical, device, diagnostic, generic drug, and payer organizations. For more information, visit